Cargando…
Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke
BACKGROUND: The widespread use of tissue plasminogen activator (tPA), the only FDA-approved acute stroke treatment, remains limited by its narrow therapeutic time window and related risks of brain hemorrhage. Normobaric oxygen therapy (NBO) may be a useful physiological strategy that slows down the...
Autores principales: | Fujiwara, Norio, Murata, Yoshihiro, Arai, Ken, Egi, Yasuhiro, Lu, Jie, Wu, Ona, Singhal, Aneesh B, Lo, Eng H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714858/ https://www.ncbi.nlm.nih.gov/pubmed/19604385 http://dx.doi.org/10.1186/1471-2202-10-79 |
Ejemplares similares
-
Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models
por: Wu, Ona, et al.
Publicado: (2012) -
Normobaric Oxygen (NBO) Therapy Reduces Cerebral Ischemia/Reperfusion Injury through Inhibition of Early Autophagy
por: Wang, Meng, et al.
Publicado: (2021) -
Normobaric oxygen for cerebral ischemic injury
por: Chen, Chunhua, et al.
Publicado: (2013) -
Normobaric oxygen therapy attenuates hyperglycolysis in ischemic stroke
por: Cheng, Zhe, et al.
Publicado: (2020) -
Normobaric Oxygen Therapy
por: Dana, Reza
Publicado: (2012)